Dr. Hale is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-5080
Education & Training
Johns Hopkins UniversityResidency, Neurology, 2020 - 2023
Pennsylvania State University College of MedicineClass of 2019
Wake Forest UniversityBS, Biology, Summa Cum Laude, 2011 - 2015
Certifications & Licensure
MD State Medical License 2023 - 2026
PA State Medical License 2024 - 2024- American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 37 citationsAnti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory pain.Matthew B. Yuill, David E Hale, Josée Guindon, Daniel J. Morgan
Molecular Pain. 2017-09-07 - 22 citationsTolerance to WIN55,212-2 is delayed in desensitization-resistant S426A/S430A mice.Caitlin M. Nealon, Angela N. Henderson-Redmond, David E Hale, Daniel J. Morgan
Neuropharmacology. 2019-04-01 - 3 citationsDiagnosing and localizing the acute vestibular syndrome - Beyond the HINTS exam.Elizabeth Fracica, David Hale, Daniel R Gold
Journal of the Neurological Sciences. 2022-11-15
Journal Articles
- Anti-nociceptive interactions between opioids and a cannabinoid receptor 2 agonist in inflammatory painMB Yuill, DE Hale, J Guidon, DJ Morgan, Molecular Pain, 9/7/2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
